We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels.
- Authors
Leboulleux, Sophie; El Bez, Intidhar; Borget, Isabelle; Elleuch, Manel; Déandreis, Désirée; Al Ghuzlan, Abir; Chougnet, Cécile; Bidault, François; Mirghani, Haitham; Lumbroso, Jean; Hartl, Dana; Baudin, Eric; Schlumberger, Martin
- Abstract
Patients with differentiated thyroid cancer (DTC) who have a suspicious recurrent or persistent disease based on an elevated serum thyroglobulin (Tg) or Tg antibodies (TgAb) are usually referred for empiric radioiodine ((131)I) administration to localize and treat the disease. The aim of this retrospective monocentric study was to assess the sensitivity of postempiric (131)I whole-body scan (WBS) compared to 18-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in such patients who had an initial normal postablation WBS.
- Publication
Thyroid : official journal of the American Thyroid Association, 2012, Vol 22, Issue 8, p832
- ISSN
1557-9077
- Publication type
Journal Article
- DOI
10.1089/thy.2012.0081